Nowadays, it is well accepted that BMP-9 binds to ALK1 with much higher affinity than TGF-β, but the individual constellation of ligands and receptors within the microenvironment of a growing tumor probably dictates a pro- or anti-angiogenic outcome of blocking ALK1. This evidence concerns the gene ACVRL1 and neoplasm.